Condition

Breast cancer clinical trials

2,448 studies mentioning breast cancer are recruiting now. Open one to see what it involves.

Recruiting breast cancer studies right now

Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record
Study details and eligibility ClinicalTrials.gov record

Also recruiting in Europe

Trials that mention Breast cancer and that the EU Clinical Trials Information System (CTIS) lists as recruiting. Each card names the countries where recruitment is open. Open a study to see its details and a link to the European registry.

CAMBRIA-1: A Phase III, open-label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients with ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant endocrine-based Therapy Without Disease Recurrence Recruiting in Germany EU CTIS Therapeutic confirmatory (Phase III) Study details

Breast cancer clinical trials: common questions

Are breast cancer clinical trials free to join?

Taking part is generally free to you, and many trials cover study-related visits, tests, and the study drug at no cost. What's covered varies by study, and the study team confirms the details.

Do you get paid for breast cancer clinical trials?

Some studies offer compensation for your time and travel; the amount varies by study and some offer none. Any compensation is set by the study.

How do I know if I qualify for a breast cancer trial?

Each study sets its own eligibility criteria, such as age, health history, and current medications. You share a few details and the study team reviews and confirms whether you're a fit.

Is BridgeMD the study sponsor?

No. BridgeMD is a free tool that helps you find recruiting trials and apply online. Trial information comes from ClinicalTrials.gov, and the study team decides eligibility.

Breast cancer trials by city

Breast cancer in TorontoBreast cancer in VancouverBreast cancer in MontrealBreast cancer in CalgaryBreast cancer in EdmontonBreast cancer in OttawaBreast cancer in WinnipegBreast cancer in Quebec CityBreast cancer in HamiltonBreast cancer in KitchenerBreast cancer in WaterlooBreast cancer in LondonBreast cancer in HalifaxBreast cancer in New YorkBreast cancer in Los AngelesBreast cancer in ChicagoBreast cancer in HoustonBreast cancer in PhoenixBreast cancer in PhiladelphiaBreast cancer in San AntonioBreast cancer in San DiegoBreast cancer in DallasBreast cancer in MiamiBreast cancer in BostonBreast cancer in AtlantaBreast cancer in SeattleBreast cancer in DenverBreast cancer in WashingtonBreast cancer in MinneapolisBreast cancer in DetroitBreast cancer in PortlandBreast cancer in San FranciscoBreast cancer in NashvilleBreast cancer in ClevelandBreast cancer in Pittsburgh

Other conditions

BridgeMD lists breast cancer clinical trials that are currently recruiting participants, pulled live from ClinicalTrials.gov. Clinical trials study new or existing treatments and are run by hospitals, universities, and research sites. Taking part is generally free, some studies offer compensation for time and travel, and the study team confirms whether you're eligible. Enter your city or postal code above to find the studies closest to you and answer a few questions to apply. You can talk to your own doctor before joining.